Close Menu

real estate

The California-based genetic testing firm said its new lab will be able to process 20,000 tests per day and will initially focus on COVID-19 testing.

The CRISPR therapy developer is moving about a half a mile away as it launches a new division to focus on ex vivo therapies. 

The Rochester, New York-based firm is moving to Richmond, Virginia after also considering the Boston, San Francisco, and Research Triangle areas.

The 155,000-square-foot building will give the firm a home in Granta Park, a BioMed Realty Trust research center located near Cambridge University.

The firm said the office will help it strengthen ties with and provide better service to it Chinese customers.

A total of six facilities comprising more than 2 million square feet are in New York's pipeline of life-sci space, according to the panelists who spoke at the New York Biotechnology Association's annual meeting this week.

Released earlier this month, the report concluded that Arizona's life-sciences sector can expect another 11 years of steady growth if the state holds back or reverses budget cuts affecting the industry.

Researchers at Affymetrix, Genentech, and Stanford University's Genome Technology Center have created a new array-based resequencing assay that they claim is scalable enough to compete with second-generation sequencing platforms.

Top executives last week from Alexandria Real Estate Equities, BioMed Realty Trust, and HCP said life-sci shops are increasingly skittish about leasing new space for the long term, leading the REITs to reduce spending on construction and renovation projects this year.

Michael Kirschner, Vernon George, Norma Grace, Sherman McCorkle, Austin Beggs, Michael Donovan, Scott Levitan, Jinx Patel

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.